Department of Oral Biology and Diagnostic Sciences, Augusta University, Augusta, GA, USA; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Mansoura University, Egypt.
Department of Oral Biology and Diagnostic Sciences, Augusta University, Augusta, GA, USA; Department of Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt; Wayne State University, Department of Ophthalmology, Visual, and Anatomical Sciences, Department of Pharmacology, Detroit, MI.
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Nov;1864(11):1669-1680. doi: 10.1016/j.bbalip.2019.07.009. Epub 2019 Jul 23.
Recent studies suggest a potential role of bioactive lipids in acute kidney injury induced by lipopolysaccharide (LPS). The current study was designed to determine the profiling activities of various polyunsaturated fatty acid (PUFA) metabolizing enzymes, including lipoxygenases (LO), cyclooxygenase, and cytochrome P450 in the plasma of LPS-injected mice using LC-MS. Heat map analysis revealed that out of 126 bioactive lipids screened, only the 12/15-LO metabolite, 12-HETE, had a significant (2.24 ± 0.4) fold increase relative to control (P = 0.0001) after Bonferroni Correction (BCF α = 0.003). We then determined the role of the 12/15-LO in LPS-induced acute kidney injury using genetic and pharmacological approaches. Treatment of LPS injected mice with the 12/15-LO inhibitor, baicalein, significantly reduced levels of renal injury and inflammation markers including urinary thiobarbituric acid reactive substance (TBARs), urinary monocyte chemoattractant protein-1 (MCP-1), renal interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). Similarly, knocking-out of 12/15-LO reduced levels of renal inflammation and injury markers elicited by LPS injection. Next, we tested whether exogenous supplementation with docosahexaenoic acid (DHA) as a substrate would divert the role of 12/15-LO from being pro-inflammatory to anti-inflammatory via increased production of the anti-inflammatory metabolite. DHA treatment restored the decreased in plasma level of resolvin D2 (RvD2) and reduced renal injury in LPS-injected mice whereas DHA treatment failed to provide any synergistic effects in reducing renal injury in LPS injected 12/15-LO knock-out mice. The ability of RvD2 to protect kidney against LPS-induced renal injury was further confirmed by exogenous RvD2 which significantly reduced the elevation in renal injury in LPS injected mice. These data suggest a double-edged sword role of 12/15-LO in LPS-induced acute renal inflammation and injury, depending on the type of substrate available for its activity.
最近的研究表明,生物活性脂质在脂多糖 (LPS) 诱导的急性肾损伤中可能发挥作用。本研究旨在使用 LC-MS 确定 LPS 注射小鼠血浆中各种多不饱和脂肪酸 (PUFA) 代谢酶,包括脂氧合酶 (LO)、环加氧酶和细胞色素 P450 的谱活性。热图分析显示,在筛选出的 126 种生物活性脂质中,只有 12/15-LO 代谢物 12-HETE 与对照相比(Bonferroni 校正后 P=0.0001)有显著的(2.24±0.4)倍增加(BCFα=0.003)。然后,我们使用遗传和药理学方法确定 12/15-LO 在 LPS 诱导的急性肾损伤中的作用。用 12/15-LO 抑制剂白杨素处理 LPS 注射小鼠,可显著降低肾损伤和炎症标志物的水平,包括尿硫代巴比妥酸反应物质 (TBARs)、尿单核细胞趋化蛋白-1 (MCP-1)、肾白细胞介素-6 (IL-6) 和肿瘤坏死因子-α (TNF-α)。同样,敲除 12/15-LO 可降低 LPS 注射引起的肾炎症和损伤标志物的水平。接下来,我们测试了外源性补充二十二碳六烯酸 (DHA) 作为底物是否会通过增加抗炎代谢物的产生,将 12/15-LO 的作用从促炎转变为抗炎。DHA 治疗恢复了 LPS 注射小鼠血浆中分辨率 D2 (RvD2) 水平的降低,并减轻了 LPS 注射小鼠的肾损伤,而 DHA 治疗未能在 LPS 注射 12/15-LO 敲除小鼠中提供任何协同减轻肾损伤的作用。外源性 RvD2 显著降低 LPS 注射小鼠肾损伤的升高,进一步证实了 RvD2 保护肾脏免受 LPS 诱导的肾损伤的作用。这些数据表明,12/15-LO 在 LPS 诱导的急性肾炎症和损伤中具有双刃剑作用,这取决于其活性的底物类型。